Drug search by name

Lutetium lu 177 dotatate Intravenous and Hepatic dysfunction

Result of checking the interaction of drug Lutetium lu 177 dotatate Intravenous and disease Hepatic dysfunction for safety when used together.

Check result:

Lutetium lu 177 dotatate Intravenous <> Hepatic dysfunction

Relevance: 23.07.2019 Reviewer: Shkutko P.M., M.D., in

When checking interaction based on authoritative sources Drugs.com, Rxlist.com, Webmd.com, Medscape.com there are contraindications or side effects that may cause harm or increase the negative effect from drug use in presence of concomitant diseases.

Consumer:

Lutetium Lu 177 dotatate does not undergo hepatic metabolism. No dose adjustment is recommended for patients with mild or moderate hepatic impairment. Care is recommended when using lutetium Lu 177 dotatate in patients with severe hepatic impairment (total bilirubin > 3 times upper limit of normal and any AST) as its safety has not been studied in these patients. Monitor transaminases, bilirubin and serum albumin during treatment.

Lutetium lu 177 dotatate Intravenous

Generic Name: lutetium lu 177 dotatate

Brand Name: Lutathera

Synonyms: Lutetium Lu 177 dotatate, Lutetium Lu 177 Dotatate

What is Lutetium lu 177 dotatate Intravenous?